Sign up USA
Proactive Investors - Run By Investors For Investors

ChimpChange raises funds to accelerate digital banking growth

The company’s revenue more than doubled in the March 2017 quarter.
ChimpChange raises funds to accelerate digital banking growth
ChimpChange launched a new savings account in April

ChimpChange (ASX:CCA) has successfully completed a placement to institutional and sophisticated investors, raising $10 million at $0.72 per share.

Based in Los Angeles, California, ChimpChange is a digital banking platform providing low-cost, feature-rich bank accounts for U.S. consumers.

ChimpChange will use the new funds to accelerate customer acquisition, product development and finalise build-out of internal enterprise software development capabilities.

The company’s revenue more than doubled in the March 2017 quarter compared to the previous quarter and achieved an annualised A$1 million revenue run rate ahead of forecast.

Furthermore, ChimpChange finished the March quarter with total transaction value running at an annualised run rate of US$118+ million, up from US$56 million at the end of the December quarter.

The company launched a new savings account in April with round-up feature following successful pilot during the quarter.

In the new account, the difference between the nearest whole dollar and the actual purchase price from every MasterCard transaction is saved in a separate round-up account.

The round-up account will grow over time as the customer proactively swipes their debit card.

From a longer-term perspective, ChimpChange expects loan products to drive a step change in the company’s ability to generate revenue (and gross margin) per active customer.

ChimpChange’s share price increased circa 45% since the start of 2017, last trading at $0.81.



Register here to be notified of future CCA Company articles
View full CCA profile View Profile

Related Articles

financialanalysis.jpg
December 07 2016
Buy-and-build: Be Heard plans to build a mid-sized network that combines scale, expertise and agility
Theralase.png
April 04 2017
Unlike many fledgling med-tech companies it is generating revenues and thinks there is scope to significantly increase turnover in the next few years.
shutterstock_302650592_58dc0a99d5fca.jpg
March 29 2017
This week the firm has bolstered its coffers to the tune of over $20mln via a now closed bought deal financing.
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use